Skip to main content
SpringerLink
Log in
Book cover

Liver Disease in Clinical Practice pp 91–110Cite as

Alcoholic Hepatitis

  • Chapter
  • First Online:

  • 1413 Accesses

Part of the book series: In Clinical Practice ((ICP))

Abstract

Please answer if the following statements are true or false:

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Sheron N, Gilmore I, et al. Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales. BMJ. 2016;353:i1860.

    Article  PubMed  Google Scholar 

  2. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut. 1997;41:845–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lucey MR, Mathurin P, Morgan TR, et al. Alcoholic hepatitis. N Engl J Med. 2009;360:2758–69.

    Article  CAS  PubMed  Google Scholar 

  4. Vaillant GE. The natural history of alcoholism revisited. Boston: Harvard University Press; 1995.

    Google Scholar 

  5. You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1–6.

    Article  CAS  PubMed  Google Scholar 

  6. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem. 2003;278:27997–8004.

    Article  CAS  PubMed  Google Scholar 

  7. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 2004;127:1798–808.

    Article  CAS  PubMed  Google Scholar 

  8. Cohen SM, Ahn JSO. The diagnosis and management of alcoholic hepatitis. Aliment Pharmacol Ther. 2009;30(1):3–13.

    Article  CAS  PubMed  Google Scholar 

  9. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, Schiff ER, McClain CJ, Marsano LS, Allen JI. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology. 1993;17(4):564–76.

    Article  CAS  PubMed  Google Scholar 

  10. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997;25(1):108–11.

    Article  CAS  PubMed  Google Scholar 

  11. Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, Record C, Day CP. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol. 2007;47(2):277.

    Article  CAS  PubMed  Google Scholar 

  12. Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O’Grady J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis–a randomised clinical trial. J Hepatol. 2006;44(4):784–90.

    Article  CAS  PubMed  Google Scholar 

  13. Choi G, Runyon BA. Alcoholic hepatitis: a clinician’s guide. Clin Liver Dis. 2012;16(2):371–85.

    Article  PubMed  Google Scholar 

  14. Cohen JA, Kaplan MM. The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci. 1979;24:835–8.

    Article  CAS  PubMed  Google Scholar 

  15. Mutimer DJ, Burra P, Neuberger JM, et al. Managing severe alcoholic hepatitis complicated by renal failure. Q J Med. 1993;86:649–56.

    Article  CAS  PubMed  Google Scholar 

  16. Maddrey WC, Boitnott JK, Bedine MS, Weber Jr FL, Mezey E, White Jr RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193–9.

    CAS  PubMed  Google Scholar 

  17. Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation andvalidation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353–8.

    Article  PubMed  Google Scholar 

  19. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348–54.

    Article  CAS  PubMed  Google Scholar 

  20. Forrest EH, Morris AJ, Stewart S, et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut. 2007;56:1743–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Srikureja W, Kyulo NL, Runyon BA, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol. 2005;42:700–6.

    Article  PubMed  Google Scholar 

  22. Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2002;2:2.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, El-Serag HB, Kanwal F. Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review. Clin Gastroenterol Hepatol. 2016;14(2):191–202.e4. Epub 2015 Aug 6.

    Article  PubMed  Google Scholar 

  24. Mathurin P, O’Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60(2):255–60. Epub 2010 Oct 12.

    Article  CAS  PubMed  Google Scholar 

  25. Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, Downs N, Gleeson D, MacGilchrist A, Grant A, Hood S, Masson S, McCune A, Mellor J, O’Grady J, Patch D, Ratcliffe I, Roderick P, Stanton L, Vergis N, Wright M, Ryder S, Forrest EH, STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372(17):1619–28.

    Article  CAS  PubMed  Google Scholar 

  26. Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A, Pageaux GP, Leroy V, Dharancy S, Louvet A, Boleslawski E, Lucidi V, Gustot T, Francoz C, Letoublon C, Castaing D, Belghiti J, Donckier V, Pruvot FR, Duclos-Vallée JC. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365(19):1790–800.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Queen Elizabeth Hospital Liver Unit, Birmingham, UK

    Farhan Gohar

  2. Department of gastroenterology and Hepatology, The Royal Liverpool Hospital, Prescot Street, Liverpool, L7 8XP, UK

    Farhan Gohar & Paul Richardson

Authors
  1. Farhan Gohar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Richardson .

Editor information

Editors and Affiliations

  1. Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom

    Tim Cross

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gohar, F., Richardson, P. (2017). Alcoholic Hepatitis. In: Cross, T. (eds) Liver Disease in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-43126-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43126-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43125-3

  • Online ISBN: 978-3-319-43126-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation